Susquehanna Fundamental Investments’s Adverum Biotechnologies ADVM Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,408	Closed	-$31K	–	1407
2021 Q3	$31K	Sell	1,408 -4,310	-75%	-$110K	﹤0.01%	1670
2021 Q2	$200K	Buy	+5,718	New	+$308K	﹤0.01%	1485
2021 Q1	–	Sell	-6,400	Closed	-$694K	–	1518
2020 Q4	$694K	Buy	6,400 +760	+13%	+$94K	0.01%	982
2020 Q3	$581K	Buy	5,640 +2,850	+102%	+$427K	0.02%	833
2020 Q2	$583K	Buy	+2,790	New	+$494K	0.03%	575

Other funds holding ADVM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna Fundamental Investments's ADVM Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 1,408 shares — an estimated $31K sold.

Susquehanna Fundamental Investments first reported a position in ADVM in Q2 2020 and held it in 5 quarters. The position peaked at $694K in Q4 2020. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

Susquehanna Fundamental Investments reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 1,408 Adverum Biotechnologies shares in Q4 2021, an estimated $31K.
Susquehanna Fundamental Investments first reported a position in Adverum Biotechnologies in Q2 2020 and held it in 5 quarters.
Susquehanna Fundamental Investments's Adverum Biotechnologies position peaked at $694K in Q4 2020.
98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.